Selected article for: "cell count and clinical outcome"
Author: Larsson, Mattias; Nguyen, Lien Ha Thi; Wertheim, Heiman FL; Dao, Trinh Tuyet; Taylor, Walter; Horby, Peter; Nguyen, Trung Vu; Nguyen, Minh Ha Thi; Le, Thuy; Nguyen, Kinh Van
Title: Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam
  • Cord-id: y7urtkxo
  • Document date: 2012_8_16
    • ID: y7urtkxo
    Snippet: OBJECTIVE: This study reports the clinical characteristics and outcome of HIV-associated Penicilliummarneffei infection in northern Vietnam. METHODS: We conducted a retrospective chart review of all patients with laboratory confirmed Penicilliummarneffei infection admitted to the National Hospital for Tropical Diseases in Hanoi, Vietnam, between July 2006 and September 2009. RESULTS: 127 patients with P. marneffei infection were identified. All were HIV-infected; median CD4+ T-cell count was 24
    Document: OBJECTIVE: This study reports the clinical characteristics and outcome of HIV-associated Penicilliummarneffei infection in northern Vietnam. METHODS: We conducted a retrospective chart review of all patients with laboratory confirmed Penicilliummarneffei infection admitted to the National Hospital for Tropical Diseases in Hanoi, Vietnam, between July 2006 and September 2009. RESULTS: 127 patients with P. marneffei infection were identified. All were HIV-infected; median CD4+ T-cell count was 24 cells/μl (IQR:12-48); 76% were men. Common clinical features were fever (92.9%), skin lesions (82.6%), hepatomegaly (61.4%), lymphadenopathy (40.2%), weight loss (59.1%) and cough (49.6%). Concurrent opportunistic infections were present in 22.0%; half of those had tuberculosis. Initial treatment regimens were: itraconazole or ketoconazole capsule (77.2%), amphotericin B (20.5%), and fluconazole (1.6%). In-hospital mortality was 12.6% and showed no significant difference in patients treated with itraconazole (or ketoconazole) and amphotericin B (p = 0.43). Dyspnea, ascites, and increased LDH level were independent predictors of mortality. No seasonality was observed. CONCLUSION: The clinical features, treatments and outcomes of HIV-associated P. marneffei infection in northern Vietnam are similar to those reported in other endemic regions. Dyspnea was an important predictor of mortality. More patients were treated with itraconazole than amphotericin B and no significant difference in treatment outcome was observed. It would be of clinical value to compare the efficacy of oral itraconazole and amphotericin B in a clinical trial.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute ards respiratory distress syndrome and lung dyspnea: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung lesion: 1
    • acute ards respiratory distress syndrome and lymph node: 1, 2
    • acute ards respiratory distress syndrome and lymph node aspirate: 1
    • admission date and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • admission date and logistic regression model: 1, 2
    • admission date and lung involvement: 1, 2
    • admission date and lymph node: 1
    • logistic regression and lung dyspnea: 1, 2, 3
    • logistic regression and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • logistic regression and lung lesion: 1, 2, 3, 4, 5
    • logistic regression and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • logistic regression model and lung involvement: 1, 2, 3, 4, 5, 6
    • logistic regression model and lymph node: 1, 2, 3
    • lung involvement and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lung lesion and lymph node: 1, 2